Pifithrin-α (chemical name 2-(2-Imino-4,5,6,7-tetrahydrobenzothiazol-3-yl)-1-p-tolylethanone hydrobromide[1]) is a chemical compound which acts as an inhibitor of the tumour-suppressing and epileptogenic protein p53.[2][3] It has a molecular weight of 367.30 and is soluble in DMSO up to 20 mg/mL. Its melting point is 192.1-192.5 °C.

References

  1. ^ "sigmaaldrich.com". Merck.
  2. ^ George SL, Parmar V, Lorenzi F, Marshall LV, Jamin Y, Poon E, Angelini P, Chesler L. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. J Exp Clin Cancer Res. 2020 May 6;39(1):78. doi:10.1186/s13046-020-01582-2 PMID 32375866
  3. ^ Gupta V, Singh S, Singh TG. Pervasive expostulation of p53 gene promoting the precipitation of neurogenic convulsions: A journey in therapeutic advancements. Eur J Pharmacol. 2024 Nov 15;983:176990. doi:10.1016/j.ejphar.2024.176990 PMID 39251181


Allikas: http://en.wikipedia.org/wiki/Pifithrin
No tags for this post.